Yahoo
    Swiss - Delayed Quote CHF

    Newron Pharmaceuticals S.p.A. (NWRN.SW)

    Get top stock picks
    11.76 -0.26 (-2.16%)
    At close: September 7 at 5:31:59 PM GMT+2
    Get top stock picks
    Loading Chart for NWRN.SW
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference

    Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
    GlobeNewswire 4d ago
    Newron Announces AGM 2026 Results

    Newron Announces AGM 2026 Results
    NewMediaWire 4mo ago
    European Growth Companies With High Insider Ownership In May 2026

    European Growth Companies With High Insider Ownership In May 2026
    Simply Wall St. 4mo ago
    European Growth Stocks With Insider Influence May 2026

    European Growth Stocks With Insider Influence May 2026
    Simply Wall St. 4mo ago
    European Growth Leaders With High Insider Ownership

    European Growth Leaders With High Insider Ownership
    Simply Wall St. 4mo ago
    European Growth Companies With High Insider Ownership In May 2026

    European Growth Companies With High Insider Ownership In May 2026
    Simply Wall St. 4mo ago
    Newron Pharmaceuticals S.p.A. (VTX:NWRN) Analysts Are Cutting Their Estimates: Here's What You Need To Know

    Newron Pharmaceuticals S.p.A. (VTX:NWRN) Analysts Are Cutting Their Estimates: Here's What You Need To Know
    Simply Wall St. 5mo ago
    Newron Pharmaceuticals S.p.A. (VTX:NWRN) Analysts Just Slashed This Year's Estimates

    Newron Pharmaceuticals S.p.A. (VTX:NWRN) Analysts Just Slashed This Year's Estimates
    Simply Wall St. 5mo ago
    Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)

    Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
    GlobeNewswire 5d ago
    Newron Provides Update Following Type A Meeting With the FDA

    Newron Provides Update Following Type A Meeting With the FDA
    Business Wire 2mo ago
    European Growth Stocks Insiders Are Eager To Own

    European Growth Stocks Insiders Are Eager To Own
    Simply Wall St. 4mo ago

    Related Tickers

    SANN.SW
    XLS.SW
    T9G.SG
    ADXN.SW
    IDIA.SW
    IPH.PA
    MOLN.SW
    MMTX.SW
    POXEL.PA
    B1Q.BE
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: